Posted On: 08/26/2014 10:34:35 AM
Post# of 5066
Popo,
Thank you for the DD and clear response. If Regen owns the rights to all applications to "inhibit the enzyme indolamine 2,3 deoxygenase (IDO)" through RRNAI technology, then that is promising news, especially if it proves true that the most effective way to stop cancer is through this pathway.
Googled the process to see if any competitors were approaching this aspect and while I didn't spend a lot of time, I was comforted to see that some research articles going back a few years had either Dr. Min or Dr. Ichim as part of the process.
Don't know how far away we are, but will wait this out from a distance and not constant ticker watching to see if we get any real, concrete news of where things stand within the next month.
Sure would be nice, even if they were to say, "Because of A, B, and C, we are now pushed back to expecting a 6 month delay in achieving x,y.z."
At this point, no news is worse than bad news that could be overcome.
Thanks.
Thank you for the DD and clear response. If Regen owns the rights to all applications to "inhibit the enzyme indolamine 2,3 deoxygenase (IDO)" through RRNAI technology, then that is promising news, especially if it proves true that the most effective way to stop cancer is through this pathway.
Googled the process to see if any competitors were approaching this aspect and while I didn't spend a lot of time, I was comforted to see that some research articles going back a few years had either Dr. Min or Dr. Ichim as part of the process.
Don't know how far away we are, but will wait this out from a distance and not constant ticker watching to see if we get any real, concrete news of where things stand within the next month.
Sure would be nice, even if they were to say, "Because of A, B, and C, we are now pushed back to expecting a 6 month delay in achieving x,y.z."
At this point, no news is worse than bad news that could be overcome.
Thanks.
(0)
(0)
